NJOY

NJOY is a leading independent electronic nicotine device (ENDS) company in the U.S., dedicated to eradicating combustible cigarettes. Founded in 2006, the company has been a trusted brand for adult smokers seeking satisfying alternatives to traditional cigarettes. In April 2022, NJOY achieved a historic milestone as the US Food and Drug Administration granted Marketing Orders for its ACE Device and Pods, affirming their positive impact on public health. This distinction makes NJOY the sole independent entity outside of Big Tobacco to receive such recognition.

The company's commitment to public health is further evidenced by its collaboration with the National Institute of Drug Abuse (NIDA) to develop the Standard Research Electronic Cigarette for government-funded clinical studies. The ongoing pursuit of its mission is woven into the fabric of the organization, reflected in its last investment of $5.00M in a Private Equity Round in March 05, 2021, with participation from Alpha Wave Global, ArmaVir Partners, and 44 Capital Investments.

NJOY presents a compelling opportunity for venture capital firms seeking to support a transformative force in the consumer electronics and manufacturing industries, with a powerful mission and a track record of innovation and regulatory validation.